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Abstract
Background: Cerebral cytoplasmatic redox state is a sensitive indicator of cerebral
oxidative metabolism and is conventionally evaluated from the extracellular lactate/
pyruvate (LP) ratio. In the present experimental study of global cerebral ischemia
induced by hemorrhagic shock, we investigate whether the LP ratio obtained from
microdialysis of cerebral venous blood may be used as a surrogate marker of global
cerebral energy state.
Methods: Six female pigs were anesthetized and vital parameters were recorded.
Microdialysis catheters were placed in the left parietal lobe, the superior sagittal
sinus, and the femoral artery. Hemorrhagic shock was achieved by bleeding the
animals to a mean arterial pressure (MAP) of approximately 40 mmHg and kept
at a MAP of about 30–40 mmHg for 90 min. The animals were resuscitated with
autologous whole blood followed by 3 h of observation.
Results: The LP ratio obtained from the intracerebral and intravenous catheters
immediately increased during the period of hemorrhagic shock while the LP ratio in
the arterial blood remained close to normal levels. At the end of the experiment,
median LP ratio (interquartile range) obtained from the intracerebral, intravenous,
and intra-arterial microdialysis catheters were 846 (243–1990), 309 (103–488), and 27
(21–31), respectively. There was a significant difference in the LP ratio obtained from
the intravenous location and the intra-arterial location (P < 0.001).
Conclusions: During cerebral ischemia induced by severe hemorrhagic shock,
intravascular microdialysis of the draining venous blood will exhibit changes of the
LP ratio revealing the deterioration of global cerebral oxidative energy metabolism.
In neurocritical care, this technique might be used to give information regarding
global cerebral energy metabolism in addition to the regional information obtained
from intracerebral microdialysis catheters. The technique might also be used to
evaluate cerebral energy state in various critical care conditions when insertion of an
intracerebral microdialysis catheter may be contraindicated, e.g., resuscitation after
cardiac standstill, open-heart surgery, and multi-trauma.
Keywords: Hemorrhagic shock, Microdialysis, Cerebral energy state, Ischemia
Background
Intracerebral microdialysis with bedside analysis and display of chemical variables re-
lated to cerebral energy metabolism, excitotoxicity, and cell membrane degradation has
been available as a clinical routine technique for almost 20 years [1–3]. As the micro-
dialysis probe reflects the biochemistry from a very narrow zone surrounding the
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dialysis membrane, appropriate positioning and documentation of the position of the
catheter in relation to focal lesions is necessary for a correct interpretation of the data
obtained [4]. During neurocritical care, e.g., following traumatic brain injury, information
regarding global cerebral energy state in addition to the regional information obtained
from conventional intracerebral microdialysis would be valuable. Such information would
also be of importance during critical care of other severe conditions when cerebral energy
metabolism may be jeopardized without focal lesions (e.g., open-heart surgery, resuscita-
tion after cardiac standstill, hemorrhagic or septic shock, toxic states). However, in these
conditions, it is for various reasons difficult or impossible to insert intracerebral catheters.
It would be of interest to develop an alternative technique that avoids the penetration of
cerebral tissue by the microdialysis catheter and still gives continuous bedside information
regarding cerebral energy state.
Cerebral cytoplasmatic redox state is a sensitive indicator of cerebral oxidative me-
tabolism and is conventionally evaluated from the extracellular lactate/pyruvate (LP)
ratio [5–8]. During insufficient oxygen supply (e.g., arterial hypoxia, ischemia), the LP
ratio monitored by intracerebral microdialysis increases instantaneously and if oxy-
genation is rapidly restored, it returns to a normal or near-normal level [9]. When
cerebral oxidative metabolism is compromised by mitochondrial dysfunction, a lasting
increase of the LP ratio is observed [8, 10, 11]. Although lactate and pyruvate are
water-soluble, they rapidly equilibrate over cell membranes as well as the blood-brain
barrier [12–14]. Accordingly, from a theoretical point of view, it might be possible to
evaluate changes in global cerebral redox state by monitoring the LP ratio of the cere-
bral venous outflow.
In the present experimental study, we explore whether cerebral venous LP ratio may
be used as a surrogate marker for compromised cerebral oxidative metabolism during
hemorrhagic shock. Accordingly, we test the hypothesis that the LP ratio monitored in
the cerebral venous outflow reflects the cerebral energy metabolism during compro-
mised conditions and hence is different from the LP ratio monitored in the arterial
blood.
Methods
The study was approved by the National Committee on Animal Research Ethics
(2013-15-2934). The depth and duration of hemorrhagic shock necessary for producing
cerebral ischemia that caused a compromised energy state and degradation of cell mem-
branes as evaluated from biochemical variables obtained by microdialysis were based on
four pilot studies. When the experimental model had been defined, six female pigs ap-
proximately 4 months old weighing 42 (35–45) kg were included in the study.
Anesthesia, mechanical ventilation, and surgical preparation
The porcine model of hemorrhagic shock has been previously described [15]. The ani-
mals were fasted overnight with access to ad libitum water. Sedation was achieved with
a standard mixture of medetomedin (0.05 mg/Kg), midazolam (0.25 mg/Kg), and atro-
pine (0.25 mg/Kg). Anesthesia was induced with midazolam (0.625 mg/Kg) and keta-
mine (12.5 mg/Kg) and maintained with infusion of midazolam (5 mg/Kg/h) and
fentanyl (50 μg/Kg/h). The animals were intubated and volume-controlled ventilated
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(Siemens 900 Ventilator; Siemens Elema, Stockholm, Sweden) with a tidal volume of
10 mL/kg and FiO2 of 0.30. PaCO2 was kept between 4 and 6 kPa and body
temperature around normal 38.5 °C.
Multimodal monitoring
After establishing anesthesia, one sheath was inserted into the carotid artery for blood
pressure monitoring and blood gas sampling, while the external jugular vein was can-
nulated for insertion of a pulmonary artery catheter (CCOmbo; Edwards Lifesciences,
Irvine, CA, USA) to monitor cardiac output (CO), core temperature, and central ven-
ous pressure (CVP). Arterial blood gases (PaCO2, PaO2, pH), blood glucose electrolytes,
and lactate levels were measured every 30 min (ABL800 FLEX, Radiometer Denmark).
One femoral artery was cannulated for withdrawing and re-infusing blood during the
induced hemorrhagic shock. Another sheath was placed in the contralateral femoral ar-
tery, and a microdialysis catheter (CMA 70 Bolt, M Dialysis AB, Stockholm, Sweden)
was inserted. A small craniotomy was placed in the frontal bone in the midline above
the superior sagittal sinus. The sinus was cannulated by a standard 18G peripheral ven-
ous catheter, and one microdialysis catheter (CMA 70 Bolt, M Dialysis AB, Stockholm,
Sweden) was introduced in the posterior direction and placed in the posterior part of
the superior sagittal sinus. The superior sagittal sinus was chosen for analysis of cere-
bral venous blood due to the anatomic characteristics of the experimental animal. In
the pig, most of cerebral blood is drained via paraspinal venous plexa and only a
minor part passes into the internal jugular vein [16]. A third microdialysis catheter
(CMA 70, M Dialysis AB, Stockholm, Sweden) was inserted 20 mm into the left par-
ietal lobe and one probe for monitoring brain tissue oxygenation (PbtO2) (Licox
CC1SB, Integra Neurosciences Ltd., NJ, USA) was introduced 15 mm into the contra-
lateral parietal lobe. A transducer for monitoring intracranial pressure (ICP) (Camino,
Integra Neurosciences Ltd., NJ, USA) was placed in the right hemisphere. A bladder
catheter was placed for urine collection. All animals were given a baseline dose of
200 U/kg of heparin and supplemented hourly with 100 U/kg for anticoagulation during
the hemorrhage period. At the end of experiment, the anesthetized animals were killed
with an i.v. injection of sodium pentobarbital 200 mg/mL in concentrated ethanol.
Experimental protocol
Following a 120-min baseline period allowing animals to stabilize, the following sur-
gery hemorrhagic shock was achieved by bleeding the animals to a pre-defined MAP
of approximately 40 mmHg at a rate of 2.15 mL/kg/min over 7 min and then
1.15 mL/kg/min over the remaining period [15]. Animals were kept at a MAP of
about 30–40 mmHg by withdrawing or infusing shed blood that was stored in a
citrated glucose solution at 37 °C. Following 90 min of hemorrhagic shock, the ani-
mals were resuscitated by re-infusing the shed blood at a rate of 120 mL/min until
all blood was returned. The pigs were observed for 3 h after hemorrhagic shock. Mi-
crodialysis probes were perfused with artificial CSF (M Dialysis AB, Stockholm,
Sweden) at a rate of 0.3 μl/min (CMA 106 MD pump, M Dialysis AB, Stockholm,
Sweden). The dialysates were collected in microvials and immediately analyzed for
glucose, lactate, pyruvate, glutamate, and glycerol every 30 min using an ISCUSFlex
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analyzer (M Dialysis AB, Stockholm, Sweden). After insertion, all probes were
allowed a minimum of 2 h for stabilization.
PbtO2 data were collected using the AC3.1 monitor (Integra Neurosciences Ltd.) and
recorded every 20 s. All Licox probes were tested against atmospheric air and against
each other before insertion and after removal. After insertion, appropriate function was
confirmed by an oxygen challenge test.
ICP was monitored continuously and data were collected by a CAM01 monitor (Integra
Neurosciences Ltd., NJ, USA) and ICP. Cerebral perfusion pressure (CPP) was calculated
as MAP − ICP.
Statistics
Data are given as median (interquartile range) unless otherwise noted. To test our hypoth-
esis, the time course of the LP ratio in the superior sagital sinus and femoral artery was
modeled utilizing a mixed-effects model for repeated measurements with time and loca-
tion of microdialysis probe as random effects and each animal as fixed effect. The null hy-
pothesis was that no difference in the LP ratio was found between the superior sagital
sinus and femoral artery. A p value below 0.05 was considered significant. Data analysis
was performed in Stata 11.1 statistical software (StataCorp, College Station, TX, USA).
Results
Table 1 gives the physiological and general biochemical variables monitored during the
experimental period. During the period of hemorrhagic shock, CPP decreased to about
30 mmHg causing a decrease in PbtO2 to a very low level (<5 mmHg). After re-
infusion of autologous blood, MAP increased close to baseline levels. As ICP continued
to increase during the observation period, the CPP remained low (approximately
40 mmHg). The PbtO2 remained at very low levels after re-infusion of blood. The rela-
tion between MAP and PbtO2 is illustrated in Fig. 1. During and after the shock period,
PaO2, PaCO2, and b-glucose remained within normal limits. b-Lactate increased and b-
pH decreased during the period of hemorrhagic shock, and both essentially normalized
during the observation period. Median blood loss was 1072 mL (964–1498 mL) and
median blood loss per kilogram was 31 mL/kg (26–37 mL/kg).
Table 2 gives the biochemical variables obtained from microdialysis catheters positioned
in the cerebral hemisphere, in the superior sagittal sinus, and in the femoral artery, respect-
ively. Before the induction of hemorrhagic shock, LP ratios were similar (11–18) in all three
catheter positions and within normal limits [17]. In the cerebral hemisphere, hemorrhagic
shock caused a marked increase of the LP ratio that increased further after re-infusion of
blood. The increase of the LP ratio was caused by a pronounced increase in lactate
simultaneously with a pronounced and lasting decrease in pyruvate. Intracerebral
glucose decreased and remained at a very low level during the whole study period
(<1 mmol/L). Extracellular intracerebral glutamate and glycerol increased during the
shock period and remained at very high levels after re-infusion of blood.
In the superior sagittal sinus, the LP ratio increased during the shock period and con-
tinued to increase to a very high level (100–500) after blood transfusion. In the femoral
artery, the shock period was associated with a modest increase of the LP ratio but
remained close to the upper reference level (30) in normal cerebral tissue [17]. In the
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Table 1 General physiological and biochemical variables doing hemorrhagic shock
Elapsed time (min) MAP (mmHg) ICP (mmHg) CPP (mmHg) PbtO2 (kPa) PaO2 (kPa) PaCO2 (kPa)
S −60 102 (96–111) 7 (3–11) 95 (90–106) 16 (14–27) 25 (24–27) 6.0 (5.2–6.1)
S 77 (73–99) 8 (2–12) 72 (64–93) 22 (16–31) 24 (23–25) 5.7 (5.4–6.0)
0 40 (40–40) 8 (6–8) 32 (28–34) 13 (7–18) 24 (23–25) 5.6 (5.5–5.6)
30 37 (33–39) 5 (1–9) 29 (29–31) 5 (2–8) 25 (25–26) 5.9 (5.2–6.5)
60 34 (32–36) 5 (0–8) 29 (28–31) 2 (1–3) 24 (24–25) 5.7 (5.2–6.0)
90 31 (31–33) 6 (0–13) 32 (25–43) 1 (1–2) 26 (26–28) 5.0 (4.6–7.2)
120 59 (46–84) 17 (13–22) 51 (38–62) 3 (1–4) 25 (24–26) 5.6 (4.5–6.3)
150 60 (58–65) 19 (14–28) 46 (46–47) 11 (1–21) 22 (22–24) 6.5 (5.6–7.3)
180 63 (61–99) 27 (20–34) 42 (41–65) 1 (1–9) 23 (22–23) 5.1 (4.6–5.7)
210 61 (59–65) 23 (21–31) 42 (40–42) 1 (1–5) 22 (21–22) 5.4 (4.8–5.6)
240 73 (50–104) 29 (24–39) 47 (39–49) 1 (1–1) 22 (21–23) 6.1 (5.4–6.4)
Elapsed time (min) b-Hemoglobin (mM/L) HR (bpm) b-Glucose (mM/L) b-Lactate (mM/L) b-pH Diuresis (mL)
S −60 5.7 (5.3–5.8) 78 (75–84) 6.8 (6.4–7.1) 1.5 (1.3–1.7) 7.43 (7.40–7.47) 40 (4–106)
S 5.6 (5.2–5.9 90 (78–93) 7.2 (6.8–7.7) 1.2 (1.0–1.4) 7.45 (7.43–7.46) 115 (82–160
0 4.9 (4.7–4.9) 135 (107–138) 9.7 (8.9–9.8) 2.5 (2.0–3.0) 7.41 (7.41–7.43) 12 (0–23)
30 4.6 (4.5–4.7) 116 (111–146) 8.6 (7.7–14.4) 5.3 (3.7–7.4) 7.34 (7.32–7.38) 4 (3–5)
60 5.2 (4.9–5.5) 166 (129–191 7.9 (6.2–13.1) 7.2 (4.7–11.1) 7.30 (7.25–7.41) 2 (1–5)
90 5.2 (5.2–5.4) 125 (114–168) 7.0 (4.8–9.2) 10.3 (6.0–10.3) 7.20 (7.18–7.31) 3 (2–10)
120 5.1 (4.6–5.6) 98 (93–116) 6.2 (5.2–7.0) 5.5 (4.4–6.5) 7.29 (7.21–7.34) 16 (5–31)
150 5.2 (5.1–5.6) 101 95–120) 6.4 (4.9–7.6) 4.8 (3.6–6.9) 7.20 (7.19–7.24) 20 (17–25)
180 5.5 (5.2–5.8) 110 (103–113) 6.5 (5.7–8.5) 2.5 (2.1–3.7) 7.43 (7.33–7.50) 70 (25–70)
210 5.5 (5.3–5.7) 122 (88–128) 4.5 (3.9–5.4) 2.1 (1.7–3.3) 7.43 (7.39–7.43) 45 (5–45)
240 5.8 5.7–5.8) 17 (105–121) 5.5 (4.6–6.1) 2.0 (1.2–3.0) 7.36 (7.33–7.47) 18 (5–100)
Data are expressed as median levels (interquartile range). S indicates the start of bleeding to achieve a MAP of 40 mmHg
MAP mean arterial pressure, ICP intracranial pressure, CPP cerebral perfusion pressure, PbtO2 brain tissue oxygenation.
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superior sagittal sinus, the pronounced increase in the LP ratio was caused by a marked in-
crease in lactate simultaneously with a marked decreased in pyruvate. In the femoral ar-
tery, the increase in lactate concentration was accompanied by a simultaneous increase in
pyruvate limiting the increase in the LP ratio. The time courses of the changes in the LP
ratios in the sagittal sinus and femoral artery are shown in Fig. 2. Figure 3 shows the simul-
taneous changes in lactate concentration in the two compartments. The difference in the
LP ratio between the superior sagittal sinus and femoral artery was significant (p < 0.001).
After induction of hemorrhagic shock, glucose concentration decreased to extremely
low levels in the superior sagittal sinus that lasted during the whole study period. In
the femoral artery, glucose remained relatively constant. Already before induction of
hemorrhagic shock (control conditions), glutamate concentration was very high in the
superior sagittal sinus as well as in the femoral artery (100–200 μmol/L). In both posi-
tions, glutamate remained essentially unchanged during the study period. Glycerol con-
centration increased in the superior sagittal sinus as well as in the femoral artery
during the shock period and continued to increase after re-infusion of blood.
Discussion
Cerebral cytoplasmatic redox state is primarily determined by mitochondrial oxidative
metabolism [3–7]. It is conventionally described by the ratio between the cytoplasmatic
levels of lactate and pyruvate and is expressed in the ratio between lactate and pyruvate,
the LP ratio.
Fig. 1 Median (interquartile range) arterial pressure (MAP) and brain tissue oxygen tension (PbtO2) in pigs
with induced hemorrhagic shock. Note that during the period of hemorrhagic shock, the declining MAP
was accompanied by a decrease in PbtO2 to a very low level (<5 mmHg). After re-infusion of autologous
blood, MAP increased to close to baseline level whereas PbtO2 remained very low. S indicates the start of
bleeding to achieve a MAP of 40 mmHg. The black bar on the x-axis from 0 to 90 min indicates the shock
period before resuscitation was started
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Table 2 Biochemical variables obtained from microdialysis
Elapsed time (min) LP ratio Lactate (mM/L) Pyruvate (μM/L)
Hemisphere Sagittal sinus Femoral Hemisphere Sagittal sinus Femoral Hemisphere Sagittal sinus Femoral
S −60 15 (14–18) 13 (9–16) 11 (11–19) 20.7 (10.7–30.0) 20.1 (10.7–20.3) 10.6 (10.1–1.9) 131 (107–178) 111 (106–123) 141 (99–160)
S −30 13 (11–16) 13 (6–16) 12 (10–17) 2.9 (2.4–3.5) 2.2 (2.2–2.2) 2 (1.7–2.6) 191 (151–205) 200 (193–371) 166 (161–175)
S 15 (11–18) 14 (8–26) 13 (10–21) 2.4 (2.1–3.1) 3.4 (2.6–5.2) 2.2 (1.6–3.4) 185 (153–210) 220 (161–388) 137 (131–153)
0 20 (17–41) 45 (32–46) 33 (30–36) 7.6 (7.2–8.0) 11.1 (10.5–11.7) 3 (2.3–4.0) 110 (107–149) 178 (144–208) 181 (129–193)
30 60 (27–117) 36 (23–63) 27 (26–27) 10.3 (7.8–11.0) 6.8 (4.6–12.1) 3.8 (3.7–4.4) 143 (92–163) 222 (147–230) 181 (111–187)
60 169 (45–418) 85 (36–112) 28 (26–35) 14.6 (11.8–17.2) 9 (6.6–13.2) 5.5 (5.2–6.8) 85 (43–137) 219 (128–272) 214 (144–286)
90 351 (105–774) 78 (42–117) 29 (25–33) 14.9 (10.2–18.8) 10.2 (7.0–13.6) 7.8 (4.2–9.3) 36 (21–49) 175 (111–208) 312 (256–348)
120 704 (97–1454) 94 (63–135) 29 (25–35) 12.9 (10.2–17.2) 9.7 (8.0–12.0) 9.7 (4.0–12.9) 28 (9–64) 129 (68–232) 305 (191–348)
150 879 (115–1238) 123 (36–332) 34 (24–37) 11.2 (10.6–15.9) 8.9 (8.0–13.8) 6.4 (3.0–10.9) 24 (9–210) 80 (29–269) 266 (162–308)
180 724 (264–2479) 150 (63–308) 30 (22–34) 12.9 (9.7–14.6) 8.8 (6.8–13.1) 7 (3.5–9.8) 38 (6–158) 90 (34–168) 215 157–274)
210 846 (243–1990) 309 (103–488) 27 (21–31) 13.4 (11.2–13.8) 9.6 (8.0–14.1) 4.4 (3.1–7.7) 8 (2–94) 81 (15–150) 192 (171–286)
Elapsed time (h) Glucose (mM/L) Glutamate (μM/L) Glycerol (μM/L)
Hemisphere Sagittal sinus Femoral Hemisphere Sagittal sinus Femoral Hemisphere Sagittal sinus Femoral
S −01:00 2.4 (1.2–3.7) 3 (1.3–4.0) 5.2 (3.1–5.3) 5 (5–13) 130 (75–168) 183 (168–200) 27 (15–50) 31 (17–57) 34 (28–54)
S −00:30 2.9 (2.4–3.7) 2.9 (1.1–3.7) 4.1 (2.4–7.1) 8 (3–11) 162 (121–177) 199 (159–209) 26 (14–55) 28 (24–63) 34 (26–35)
S 3.6 (2.7–4.1) 1.7 (1.3–3.8) 3.7 (2.1–6.5 6 (4–7) 174 (104–204) 180 (148–209) 23 (13–41) 31 (23–55) 21 (20–29)
0 1.7 (1.5–1.9) – 1.2 (0.7–1.6) – 87 (50–121) 202 (169–221) 40 (40–40) 74 (49–100) 12 (11–14)
30 1.9 (1.2–2.4) 1.3 (0.6–4.2) 6.9 (1.3–9.2) 19 (4–55) 158 (84–159) 185 (163–206) 56 (32–108) 53 (37–112) 21 (8–32)
60 1.0 (0.7–1.4) 2 (0.02–2.2) 3.8 (1.1–8.2) 68 (36–101) 156 (132–204) 181 (158–204) 180 (133–201) 96 (53–159) 33 (14–117)
90 0.4 (0.3–0.5) 0.6 (0.02–1.5) 5.4 (1.7–7.6) 119 (119–119) 225 (204–248) 172 (149–195) 329 (254–337) 120 (102–190) 89 (29–486)
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Table 2 Biochemical variables obtained from microdialysis (Continued)
120 0.2 (1.0–0.3) 0.3 (0.04–0.7) 3.4 (1.2–7.3) 245 (199–291) 209 (209–209) 192 (152–198) 415 (318–455) 192 (123–258) 83 (23–671)
150 0.1 (0.1–1.0) 0.1 (0.02–0.5) 3.1 (0.5–5.6) 327 (231–329) 199 (152–259) 153 (107–177) 403 (377–548) 222 (151–286) 76 (19–621)
180 0.2 (0.1–1.3) 0.1 (0.02–0.2) 1.8 (0.5–5.9) 335 (289–367) 198 (133–256) 173 (139–180) 382 (333–547) 213 (191–230) 71 (18–314)
210 0.3 (0.1–0.9) 0.02 (0.02–0.7) 5.5 (0.9–8.1) 311 (232–322) 257 (227–287) 186 (184–188) 522 (474–612) 321 (268–331) 101 (26–182)
Data are expressed as median (interquartile range). S indicates the start of bleeding to achieve a MAP of 40 mmHg
LP lactate/pyruvate ratio
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Fig. 2 Logarithmic illustration of the LP ratios (median (interquartile range)) in the sagittal sinus and femoral
artery during hemorrhagic shock in pigs. The increase in the LP ratio in the sagittal sinus was significantly
higher (p < 0.001) than in the arterial blood. S indicates the start of bleeding to achieve a MAP of 40 mmHg.
The black bar on the x-axis from 0 to 90 min indicates the shock period before resuscitation was started
Fig. 3 Microdialysis levels of lactate (median (interquartile range)) in the sagittal sinus and femoral artery
doing hemorrhagic shock in pigs. Note that lactate levels increases in both compartments during shock.
After re-infusion of blood, lactate levels in the sagittal sinus remain at a high level throughout the monitoring
period. In contrast, the lactate levels in the femoral artery decline to a near-normal level. S indicates the start of
bleeding to achieve a MAP of 40 mmHg
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Lactate and pyruvate are water-soluble. However, due to monocarboxylate transporters
(MCTs), they equilibrate rapidly across cellular membranes. MCTs are proton-linked
membrane carriers involved in the transport of various monocarboxylates such as lactate,
pyruvate, and ketone bodies [12–14, 18]. They are present in all tissues. Out of the total
family of 14 members, three isoforms (MCT1, MCT2, MCT4) have been described in the
brain [19]. The driving forces for the transport of the monocarboxylates are obtained from
the concentration differences over the cellular membranes. The transport is consequently
characterized as facilitated diffusion [20]. The MCTs appear to be very effective in trans-
porting lactate and pyruvate. After induction of cerebral ischemia, the intracerebral micro-
dialysis probe will detect an increase in the LP ratio instantaneously and if the circulation
is rapidly restored, the LP ratio quickly returns to a normal or near-normal level [9]. Based
on these conditions, the present experimental study was designed to explore whether the
equilibration of lactate and pyruvate across the blood-brain barrier (BBB) was rapid
enough to permit the LP ratio of the draining venous blood to be used as a surrogate
marker for global cerebral redox state.
After induction of hemorrhagic shock, the intracerebral LP ratio rapidly increased to a
very high level. The increase was due to a marked increase in lactate concentration simul-
taneously with a pronounced decrease in pyruvate (Table 2, Fig. 2). This metabolic pattern
is characteristic of ischemia (i.e., a simultaneous decrease in tissue oxygenation supply and
substrate/glucose) [8–10]. After re-infusion of blood, the increase in lactate and the LP ra-
tio increased further while pyruvate concentration continued to decrease. Tissue bio-
chemical analysis thus revealed an insufficient supply of oxygen as well as substrate
during the induced hemorrhagic shock that continued after blood transfusion and
normalization of MAP.
In the superior sagittal sinus, the LP ratio exhibited a parallel though less pronounced
pattern (Table 2, Fig. 2). Like in the cerebral tissue, the microdialysis catheter in the sagit-
tal sinus continued to reveal a markedly elevated LP ratio after re-infusion of blood and
the pyruvate concentration decreased to a very low level. In the femoral artery, a modest
increase in the LP ratio and a moderate increase in the pyruvate level were obtained dur-
ing and after the induced hemorrhagic shock. During the whole experimental period, the
LP ratio of the femoral arterial blood remained close to the upper reference level (≤30) of
normal cerebral tissue [17]. The difference between the level of LP ratio in the superior
sagittal sinus and femoral artery after induction of hemorrhagic shock was highly signifi-
cant, and our null hypothesis was rejected. Accordingly, we conclude that the LP ratio
monitored in cerebral venous blood reflected the pronounced global intracerebral redox
shift and was not caused by affected energy metabolism in extracranial tissues.
As shown in Table 2 and Fig. 3, the lactate concentration in the superior sagittal sinus
increased during and after the period of shock. However, as arterial lactate level also in-
creased markedly, intravenous lactate monitoring alone cannot be used as a marker of
compromised cerebral energy metabolism.
PbtO2 and intracerebral glucose
PaO2 and b-glucose levels were kept relatively constant during the experimental period
(Table 1). In spite of this fact, PbtO2 and intracerebral glucose decreased to very low
levels during the induced hypotensive shock and remained very low after re-infusion of
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blood (Table 1, Fig. 1). This pattern is compatible with that observed during cerebral is-
chemia and corroborates the intracerebral microdialysis findings (Table 2). Accordingly,
although MAP returned to close to the initial level after blood re-infusion (Table 1),
cerebral perfusion was obviously not sufficient for restoring energy metabolism. The
finding is probably explained by the fact that a progressive increase in ICP caused a de-
crease of CPP to a low level (40 mmHg; Table 1). The reason for the progressive in-
crease in ICP is probably because of a global postischemic cytotoxic edema and leakage
of the blood-brain barrier. Due to insufficient perfusion, arterial blood glucose was vir-
tually completely extracted which resulted in a very low glucose level in the sagittal
sinus (Table 2).
Glutamate and glycerol
During clinical intracerebral microdialysis use, an increase in glutamate concentration
is generally interpreted as insufficient astrocytic uptake of released glutamate due to
energy failure [21, 22]. In the present study, intracerebral glutamate increased markedly
during the hypotensive shock period and did not return to normal level after blood re-
infusion (Table 2). Thus, the observed changes in intracerebral glutamate are in accord-
ance with the interpretation above: hypotensive shock caused cerebral ischemia and
energy failure that did not recover after blood transfusion.
The normal blood-brain barrier is not permeable to glutamate [21]. Under normal
conditions, interstitial cerebral concentration is approximately 2 μmol/L while blood
concentration is 100–200 μmol/L. Accordingly, glutamate level obtained in cerebral
venous blood does not reflect the intracerebral level. In the present study, the high con-
centration of glutamate obtained before the start of the experiment (100–200 μmol/L;
Table 2) documents that the microdialysis catheter was actually positioned in the super-
ior sagittal sinus in each experimental animals.
Intracerebral glycerol measured by microdialysis is conventionally used as a marker
of degradation of cellular membranes into free fatty acids and glycerol [23, 24]. In the
present experimental situation, intracerebral glycerol increased to a very high level dur-
ing hypotensive shock and remained at this high level after transfusion (Table 2). The
finding supports the interpretation that induced hemorrhagic shock to MAP 30 mmHg
for 90 min caused cerebral energy failure and decomposition of cellular elements. How-
ever, increase in glycerol in cerebral venous blood (Table 2) does not necessarily result
from degradation of cerebral cellular elements. The intact BBB has a very low perme-
ability for glycerol [25]. In many extracerebral tissues, triglycerides are important cellu-
lar components. During stress and increased sympathetic tonus, triglycerides are
degraded, which is reflected in fat tissue and in the blood as an increase of free fatty
acids and glycerol [26]. Accordingly, an increase in glycerol concentration was in the
present experimental situation also obtained in the femoral arterial blood (Table 2).
Clinical relevance of the experimental model
The study indicates that it is possible to evaluate global cerebral energy state by simultan-
eous monitoring of the redox state (LP ratio) in a cerebral vein. Under clinical conditions,
this could be performed by placing the venous microdialysis catheter in the internal jugu-
lar vein close to the jugular bulb. In this way, it might be possible to continuously evaluate
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cerebral energy state bedside without inserting an intracerebral probe. This technique
would be valuable in various serious conditions in need of critical care.
After cardiac standstill and resuscitation, the possibilities of evaluating cerebral dam-
age and prognosis are still limited [27–30]. In these patients, a bedside continuous
technique might also be used to monitor the effects of various therapies (e.g.,
hypothermia). For this purpose, intracerebral microdialysis has been used in a few se-
lected cases [31] but it is unlikely that this invasive technique will be used in clinical
routine. In patients subjected to open-heart surgery with or without cardiopulmonary
bypass, minor cerebral complications appear to be frequent [32–36]. In these patients,
analysis of lactate concentration from a microdialysis catheter positioned in a central
vein has been proposed [37]. Although this technique was shown to give reliable infor-
mation regarding global venous lactate level, it will not give specific information re-
garding cerebral energy metabolism. In patients with hepatic failure (HF) leading to
cerebral symptoms and coma, intracerebral microdialysis has shown that an increase in
tissue LP ratio is correlated to increases in tissue glutamine and hypoxanthine [38, 39]
and energy failure appears to be an important pathogenetic component of both acute
and chronic HF and a potential target for therapy [40].
The technique of evaluating global cerebral energy/redox state from the LP ratio ob-
tained from a microdialysis catheter positioned in the internal jugular vein might give
important information in a multitude of severe clinical conditions when direct mea-
surements of tissue biochemistry is difficult or impossible. However, it should be
recalled that evaluation of the LP ratio in the draining vein will not give quantitative,
correct information regarding cerebral extracellular LP ratio (Table 2). This is of limited
importance. Under clinical routine conditions, an upper normal level for the LP ratio is
utilized (usually 30 or 40) and the exact level of the LP ratio is often of secondary im-
portance [11, 41]. During intracerebral microdialysis, the LP ratio and the concentra-
tion of pyruvate have also been used to differentiate between ischemia and
mitochondrial dysfunction [8, 10, 11]. This kind of detailed analysis and interpretation
may not be possible when the LP ratio is monitored in cerebral venous blood.
During neurocritical care, the cerebral interstitial levels of glutamate and glycerol are
used as indicators of insufficient energy production and cellular degradation. However,
if the microdialysis catheter is positioned in cerebral venous blood, these interpreta-
tions are not valid for reasons given above.
Limitations
In experimental hemorrhagic shock, it has been described that, in contrast to the sys-
temic macrocirculation, cerebral microcirculation may be remarkably well preserved
[42]. Though the implications of this finding have been questioned, it is still an open
question when and to what degree cerebral energy metabolism is compromised during
hemorrhagic shock under clinical conditions [43]. In a recent experimental study utiliz-
ing multimodal monitoring with simultaneous imaging of cerebral hemodynamics and
NADH signals, the authors demonstrated the temporal relationship between compro-
mised microcirculation and compromised oxidative metabolism [44]. In this model of
severe hemorrhagic shock, the oxidative metabolism was not restored after re-
transfusion of the extracted blood volume. From that study and the present data, it
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appears that during severe hemorrhagic shock cerebral energy metabolism is severely
compromised exhibiting a biochemical pattern typical of ischemia. Further, if
hypotension is protracted and severe enough, cerebral energy metabolism may not be
restored after transfusion. In the present experimental study, the biochemical pattern
and the progressive increase of ICP indicated permanent cerebral lesions. The present
experimental model was chosen because it creates reproducible severe global cerebral
ischemia. However, the chosen hypotensive level of MAP around 35 mmHg is some-
what lower that the recommendations by the European Society for Intensive Care
Medicine expert panel [45]. It is therefore important to stress that the present study
cannot be used to determine the optimal level of MAP after hemorrhagic shock. The
purpose of the present study was solely to establish a technique for “non-cranial” inva-
sive monitoring of cerebral energy state. As shown in Table 2, there is a quantitative
discrepancy in the LP ratio between the cerebral microdialysis probe and the one
placed in the sinus. This suggests a “washout” effect. The degree of metabolic derange-
ment in the present study was severe. In a clinical setting, e.g., after cardiac standstill, a
less pronounced metabolic derangement will be expected. Accordingly, it might not be
possible to detect minor metabolic derangements in the venous jugular bulb due to the
washout effect. Future clinical studies are needed to determine this.
Conclusions
This experimental study documents that during protracted (≈90 min) and pronounced
(MAP≈35 mmHg) hemorrhagic shock, cerebral energy metabolism was severely com-
promised and exhibited a biochemical pattern typical of ischemia, energy failure, and
cellular degradation. After re-transfusion, this pattern was even more pronounced indi-
cating irreversible tissue damage. From intravascular microdialysis in the superior sagit-
tal sinus, it is possible to achieve semi-quantitative information of the cerebral
cytoplasmatic redox state (LP ratio) that can be separated from the biochemical alter-
ations in extracranial tissues. Accordingly, it is possible to monitor global cerebral en-
ergy state continuously with a strictly extracerebral technique. This technique might be
valuable during critical care of various severe conditions where cerebral energy metab-
olism may be compromised, e.g., resuscitation after cardiac standstill, open-heart sur-
gery, multi-trauma, hemorrhagic or septic shock, and hepatic coma. Studies are in
progress in these clinical conditions and will reveal whether the proposed technique for
evaluating global cerebral energy state will be added to the methods to measure and
monitor brain function that have evolved in recent years [46].
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